IRCT20200406046968N2
Recruiting
Phase 2
Efficacy of convalescent plasma transfusion of COVID-19 survivors on the treatment of respiratory failure of these patients
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Tabriz University of Medical Sciences
- Enrollment
- 30
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age over 18 years
- •Confirmed COVID\-19 clinically and positive PCR
- •Severe bilateral pulmonary involvement on CT scan or chest x\-ray
- •Pao2/Fio2\<300
- •Need for oxygen therapy or mechanical ventilation
Exclusion Criteria
- •Blood group incompatibility
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Investigating Effect of Convalescent Plasma on COVID-19 Patients Outcome: A Clinical TrialCOVID-19.Coronavirus infection, unspecifiedB34.2IRCT20181104041551N1Mazandaran University of Medical Sciences30
Not yet recruiting
Early Phase 1
Evaluation of Convalescent Plasma Therapy for COVID-19 PatientsIRCT20200503047281N1Yazd University of Medical Sciences40
Active, not recruiting
Not Applicable
Effectiveness and safety of plasma convalescent therapy in patients with COVID-19ISRCTN16842454Ministry of Research and Technology/National Research and Innovation Agency (Kementerian Riset dan Teknologi Republik Indonesia)5
Completed
Phase 3
Effect of convalescent plasma in COVID-19 patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/06/025803Institute of Liver and Biliary Sciences400
Completed
Phase 2
Effect of convalescent plasma in COVID-19 patientsHealth Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereCTRI/2020/04/024706Institute of Liver and Biliary Sciences29